Market research
CLV.AU Clover Corporation Limited
AU AUD Consumer Defensive
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 167M
- P/E ratio
- 16.67
- Analyst target
- 1.315
- Dividend yield
- 2.1%
- Beta
- -0.34
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- AU000000CLV2
- Market cap
- 167M
- P/E ratio
- 16.67
- Analyst target
- 1.315
- Dividend yield
- 2.1%
- Beta
- -0.34
About
About Clover Corporation Limited
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CLV.AU discussion.
5 years, 6 months ago
Clover Corporation Limited is currently in a long term uptrend where the price is trading 9.5% above its 200 day moving average.
From a valuation standpoint, the stock is 42.6% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 3.9.
Clover Corporation Limited's total revenue sank by 21.7% to $29M since the same quarter in the previous year.
Its net income has dropped by 45.8% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 223.1% to $3M since the same quarter in the previous year.
Based on the above factors, Clover Corporation Limited gets an overall score of 3/5.